nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Alzheimer disease: From biomarkers to diagnosis
|
Dubois, B. |
|
2013 |
169 |
10 |
p. 744-751 8 p. |
artikel |
2 |
Aphasia(s) in Alzheimer
|
Teichmann, M. |
|
2013 |
169 |
10 |
p. 680-686 7 p. |
artikel |
3 |
Biomarkers of Alzheimer's disease: The present and the future
|
Lehmann, S. |
|
2013 |
169 |
10 |
p. 719-723 5 p. |
artikel |
4 |
Clinical indications for analysis of Alzheimer's disease CSF biomarkers
|
Engelborghs, S. |
|
2013 |
169 |
10 |
p. 709-714 6 p. |
artikel |
5 |
Disease-specific adaptive immune biomarkers in Alzheimer's disease and related pathologies
|
Dorothée, G. |
|
2013 |
169 |
10 |
p. 715-718 4 p. |
artikel |
6 |
Démences : nouveaux concepts, nouveaux enjeux
|
|
|
2013 |
169 |
10 |
p. 677-679 3 p. |
artikel |
7 |
Editorial Board
|
|
|
2013 |
169 |
10 |
p. i- 1 p. |
artikel |
8 |
ETNA3, a clinical randomized study assessing three cognitive-oriented therapies in dementia: Rationale and general design
|
Amieva, H. |
|
2013 |
169 |
10 |
p. 752-756 5 p. |
artikel |
9 |
Executive functions in clinical and preclinical Alzheimer's disease
|
Allain, P. |
|
2013 |
169 |
10 |
p. 695-708 14 p. |
artikel |
10 |
Frontotemporal lobar degeneration and amyotrophic lateral sclerosis: Molecular similarities and differences
|
Neumann, M. |
|
2013 |
169 |
10 |
p. 793-798 6 p. |
artikel |
11 |
Frontotemporal lobar degeneration: Diversity of FTLD lesions
|
Seilhean, D. |
|
2013 |
169 |
10 |
p. 786-792 7 p. |
artikel |
12 |
Genetics of frontotemporal lobar degeneration: An up-date and diagnosis algorithm
|
Le Ber, I. |
|
2013 |
169 |
10 |
p. 811-819 9 p. |
artikel |
13 |
Intracerebral haemorrhage and cognitive decline
|
Murao, K. |
|
2013 |
169 |
10 |
p. 772-778 7 p. |
artikel |
14 |
Magnetic resonance imaging for diagnosis of early Alzheimer's disease
|
Colliot, O. |
|
2013 |
169 |
10 |
p. 724-728 5 p. |
artikel |
15 |
Neurodegenerative lesions: Seeding and spreading
|
Duyckaerts, C. |
|
2013 |
169 |
10 |
p. 825-833 9 p. |
artikel |
16 |
Neuroimaging biomarkers for Alzheimer's disease in asymptomatic APOE4 carriers
|
Chételat, G. |
|
2013 |
169 |
10 |
p. 729-736 8 p. |
artikel |
17 |
Neuropsychological assessment and cerebral vascular disease: The new standards
|
Godefroy, O. |
|
2013 |
169 |
10 |
p. 779-785 7 p. |
artikel |
18 |
New behavioural variant FTD criteria and clinical practice
|
Pasquier, F. |
|
2013 |
169 |
10 |
p. 799-805 7 p. |
artikel |
19 |
Preclinical trials in autosomal dominant AD: Implementation of the DIAN-TU trial
|
Mills, S.M. |
|
2013 |
169 |
10 |
p. 737-743 7 p. |
artikel |
20 |
Presymptomatic studies in genetic frontotemporal dementia
|
Rohrer, J.D. |
|
2013 |
169 |
10 |
p. 820-824 5 p. |
artikel |
21 |
Semantic dementia: Aspects of the early diagnosis
|
Belliard, S. |
|
2013 |
169 |
10 |
p. 806-810 5 p. |
artikel |
22 |
Towards an earlier diagnosis of Alzheimer's disease presenting with visuospatial disorders (posterior cortical atrophy)
|
Vighetto, A. |
|
2013 |
169 |
10 |
p. 687-694 8 p. |
artikel |
23 |
Vascular neuropathology and cognitive decline
|
Deramecourt, V. |
|
2013 |
169 |
10 |
p. 765-771 7 p. |
artikel |
24 |
Vascular risk factors and cognitive disorders
|
Debette, S. |
|
2013 |
169 |
10 |
p. 757-764 8 p. |
artikel |